For anyone interested (before it is available on Hot Copper):
Highlights: •Results of eight-year DENSE breast screening trial published in the New England Journal of Medicine (NEJM) •The DENSE randomised controlled trial shows a halving of interval breast cancers inwomen identified as having extremely dense breasts by Volpara®Density™ software who are then offered breast MRI •The publication of the DENSE trial results represents a significant milestone for screening—“high-quality data from a randomised trial where none existed,” states the accompanying NEJM editorial
VHT Price at posting:
$1.84 Sentiment: Buy Disclosure: Held